Receptor soluble de interleuquina.2 (RSIL-2) en sueros de individuos infectados por virus de inmunodeficiencia humana (VIH)

  • Tania Romero Adrián Universidad del Zulia-Venezuela

Abstract

Receptor soluble de interleuquina-2” (RsIL-2), fue medido en suero por el método de ELISA (T Cell Science U.S.A.) en 17 pacientes VIH positivos, 11 hombres homosexuales VIH Negativos (H.S.M.) y 22 controles (C) normales. Nuestros resultados muestran diferencias estadísticamente significantes en la liberación de RsIL-2 entre pacientes VIH positivos (684 Ó 522 Ulml) en comparación con VIH negativos (HSM) (411Ó248 U/ml) y controles (317Ó 155).

Published
1991-09-21
How to Cite
1.
Romero Adrián T. Receptor soluble de interleuquina.2 (RSIL-2) en sueros de individuos infectados por virus de inmunodeficiencia humana (VIH). Kasmera [Internet]. 1991Sep.21 [cited 2025Apr.6];19(1-4):1-12. Available from: https://mail.produccioncientificaluz.org/index.php/kasmera/article/view/4543
Issue
Vol. 19 No. 1-4 (1991)
Section
Original Articles

Copyright (c) 2012 Tania Romero Adrián

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Kasmera journal is registered under a Creative Commons an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0), available at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en; which guarantees the freedom to share-copy and redistribute the material in any medium or format and adapt-remix, transform and build from the material, provided that the name of the authors, the Department of Infectious and Tropical Diseases, Zulia´s University and Kasmera Journal, you must also provide a link to the original document and indicate if changes have been made.

The Department of Infectious and Tropical Diseases, University of Zulia and Kasmera Journal do not retain the rights to published manuscript and the contents are the sole responsibility of the authors, who retain their moral, intellectual, privacy and publicity rights. The guarantee on the intervention of the manuscript (revision, correction of style, translation, layout) and its subsequent dissemination is granted through a license of use and not through a transfer of rights, which represents the Kasmera Journal and Department Infectious Diseases, University of Zulia are exempt from any liability that may arise from ethical misconduct by the authors.

Kasmera is considered a green SHERPA/RoMEO journal, that is, it allows self-archiving of both the pre-print (draft of a manuscript) and the post-print (the corrected and peer-reviewed version) and even the final version (layout as it will be published in the journal) both in personal repositories and in institutional and databases.